{
    "Trade/Device Name(s)": [
        "Solana C. difficile Assay"
    ],
    "Submitter Information": "Quidel Corporation",
    "510(k) Number": "K170491",
    "Predicate Device Reference 510(k) Number(s)": [
        "K113358",
        "DEN120013"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OZN"
    ],
    "Summary Letter Date": "February 16, 2017",
    "Summary Letter Received Date": "February 17, 2017",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3130"
    ],
    "Regulation Name(s)": [
        "Clostridium difficile toxin gene amplification assay"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Clostridium difficile Toxin A gene (tcdA)"
    ],
    "Specimen Type(s)": [
        "Unformed stool"
    ],
    "Specimen Container(s)": [
        "Lysis Tube",
        "Dilution Tube",
        "Reaction Tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Solana instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Helicase-dependent amplification (HDA)",
        "Nucleic acid amplification",
        "Fluorescence detection"
    ],
    "Methodologies": [
        "Isothermal amplification",
        "Molecular detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Solana C. difficile Assay, a qualitative HDA-based molecular test for detecting C. difficile toxin A gene from unformed stool using the Solana instrument",
    "Indications for Use Summary": "In vitro diagnostic test for direct, qualitative detection of the Clostridium difficile Toxin A gene (tcdA) in unformed stool specimens from patients suspected of having Clostridium difficile-infection (CDI), as an aid in diagnosis, for use only with the Solana instrument",
    "fda_folder": "Microbiology"
}